Abstract
Purpose
Human papillomaviruses (HPVs) are the causative agents of cervical cancer and are also associated with other types of cancers. HPVs can modulate microRNAs (miRNAs) expressed by infected cells. The production of extracellular vesicles is deregulated in cancer, and their cargo delivered to the microenvironment can promote tumorigenesis. The involvement of HPV oncoproteins on miRNA expression in cells and exosomes was analyzed in keratinocytes transduced with E6 and E7 from mucosal HPV-16 or cutaneous HPV-38 (K16 and K38).
Methods
MiRNAs were investigated through the TaqMan Array Human MicroRNA Cards, followed by real-time RT-PCR assay for specific miRNAs. Selected miRNA targets were analyzed by Western blot and correlated to the HPV oncoproteins by specifically silencing E6 and E7 expression. Exosomes, isolated from K16 and K38 supernatants by differential centrifugations, were quantified through the vesicle-associated acetylcholinesterase activity.
Results
MiRNAs deregulated in K16 and K38 cells were identified. HPV-16 and/or HPV-38 E6 and E7 single proteins can modify the expression of selected miRNAs involved in the tumorigenesis, in particular miR-18a, -19a, -34a and -590-5p. The analysis of the content of exosomes isolated from HPV-positive cells revealed the presence of E6 and E7 mRNAs and few miRNAs. MiR-222, a key miRNA deregulated in many cancers, was identified in exosomes from K16 cells.
Conclusions
HPV E6 and/or E7 oncoprotein expression can induce the deregulation of some miRNAs. Through the production and function of exosomes, HPV oncogenes as well as HPV-deregulated miRNAs can potentiate the virus oncogenic effects in the tumor cell microenvironment.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Accardi R, Dong W, Smet A et al (2006) Skin human papillomavirus type 38 alters p53 functions by accumulation of deltaNp73. EMBO Rep 7:334–340. doi:10.1038/sj.embor.7400615
Al-Nedawi K, Meehan B, Rak J (2009) Microvesicles: messengers and mediators of tumor progression. Cell Cycle 8:2014–2018
Arroyo JD, Chevillet JR, Kroh EM et al (2011) Argonaute2 complexes carry a population of circulating microRNAs independent of vesicles in human plasma. Proc Natl Acad Sci USA 108:5003–5008. doi:10.1073/pnas.1019055108
Caldeira S, Zehbe I, Accardi R et al (2003) The E6 and E7 proteins of the cutaneous human papillomavirus type 38 display transforming properties. J Virol 77:2195–2206
Chavez-Muñoz C, Kilani RT, Ghahary A (2009) Profile of exosomes related proteins released by differentiated and undifferentiated human keratinocytes. J Cell Physiol 221:221–231. doi:10.1002/jcp.21847
Cheng Q, Yi B, Wang A, Jiang X (2013) Exploring and exploiting the fundamental role of microRNAs in tumor pathogenesis. Onco Targets Ther 6:1675–1684. doi:10.2147/OTT.S52730
Chiantore MV, Mangino G, Iuliano M et al (2015a) IFN-β antiproliferative effect and miRNA regulation in Human Papilloma Virus E6- and E7-transformed keratinocytes. Cytokine. doi:10.1016/j.cyto.2015.12.014
Chiantore MV, Mangino G, Zangrillo MS, Iuliano M, Affabris E, Fiorucci G, Romeo G (2015b) Role of the microenvironment in tumourigenesis: focus on virus-induced tumors. Curr Med Chem 22:958–974
Chu Y, Ouyang Y, Wang F et al (2014) MicroRNA-590 promotes cervical cancer cell growth and invasion by targeting CHL1. J Cell Biochem 115:847–853. doi:10.1002/jcb.24726
Columba Cabezas S, Federico M (2013) Sequences within RNA coding for HIV-1 Gag p17 are efficiently targeted to exosomes. Cell Microbiol 15:412–429. doi:10.1111/cmi.12046
Concepcion CP, Bonetti C, Ventura A (2012) The microRNA-17-92 family of microRNA clusters in development and disease. Cancer J 18:262–267. doi:10.1097/PPO.0b013e318258b60a
Corcoran C, Rani S, O’Driscoll L (2014) miR-34a is an intracellular and exosomal predictive biomarker for response to docetaxel with clinical relevance to prostate cancer progression. Prostate 74:1320–1334. doi:10.1002/pros.22848
Corney DC, Hwang CI, Matoso A et al (2010) Frequent downregulation of miR-34 family in human ovarian cancers. Clin Cancer Res 16:1119–1128. doi:10.1158/1078-0432.CCR-09-2642
De Toro J, Herschlik L, Waldner C, Mongini C (2015) Emerging roles of exosomes in normal and pathological conditions: new insights for diagnosis and therapeutic applications. Front Immunol 6:203. doi:10.3389/fimmu.2015.00203
Ferracin M, Veronese A, Negrini M (2010) Micromarkers: miRNAs in cancer diagnosis and prognosis. Expert Rev Mol Diagn 10:297–308. doi:10.1586/erm.10.11
Fiorucci G, Chiantore MV, Mangino G, Percario ZA, Affabris E, Romeo G (2012) Cancer regulator microRNA: potential relevance in diagnosis, prognosis and treatment of cancer. Curr Med Chem 19:461–474. doi:10.2174/092986712798918798
Fiorucci G, Chiantore MV, Mangino G, Romeo G (2015) MicroRNAs in virus-induced tumorigenesis and IFN system. Cytokine Growth Factor Rev 26:183–194. doi:10.1016/j.cytogfr.2014.11.002
Gallo A, Tandon M, Alevizos I, Illei GG (2012) The majority of microRNAs detectable in serum and saliva is concentrated in exosomes. PLoS ONE 7:e30679. doi:10.1371/journal.pone.0030679
Garofalo M, Quintavalle C, Romano G, Croce CM, Condorelli G (2012) miR221/222 in cancer: their role in tumor progression and response to therapy. Curr Mol Med 12:27–33
Ge R, Tan E, Sharghi-Namini S, Asada HH (2012) Exosomes in cancer microenvironment and beyond: Have we overlooked these extracellular messengers? Cancer Microenviron 5:323–332. doi:10.1007/s12307-012-0110-2
Gómez-Gómez Y, Organista-Nava J, Gariglio P (2013) Deregulation of the miRNAs expression in cervical cancer: human papillomavirus implications. Biomed Res Int 2013:407052. doi:10.1155/2013/407052
Granados López AJ, López JA (2014) Multistep model of cervical cancer: participation of miRNAs and coding genes. Int J Mol Sci 15:15700–15733. doi:10.3390/ijms150915700
Hayes J, Peruzzi PP, Lawler S (2014) MicroRNAs in cancer: biomarkers, functions and therapy. Trends Mol Med 20:460–469. doi:10.1016/j.molmed.2014.06.005
Hebner CM, Laimins LA (2006) Human papillomaviruses: basic mechanisms of pathogenesis and oncogenicity. Rev Med Virol 16:83–97. doi:10.1002/rmv.488
Honegger A, Leitz J, Bulkescher J, Hoppe-Seyler K, Hoppe-Seyler F (2013) Silencing of human papillomavirus (HPV) E6/E7 oncogene expression affects both the contents and the amounts of extracellular microvesicles released from HPV-positive cancer cells. Int J Cancer 133:1631–1642. doi:10.1002/ijc.28164
Honegger A, Schilling D, Bastian S et al (2015) Dependence of intracellular and exosomal microRNAs on viral E6/E7 oncogene expression in HPV-positive tumor cells. PLoS Pathog 11:e1004712. doi:10.1371/journal.ppat.1004712
Houzet L, Jeang KT (2011) MicroRNAs and human retroviruses. Biochim Biophys Acta 1809:686–693. doi:10.1016/j.bbagrm.2011.05.009
Kahlert C, Kalluri R (2013) Exosomes in tumor microenvironment influence cancer progression and metastasis. J Mol Med (Berl) 91:431–437. doi:10.1007/s00109-013-1020-6
Kim HK, Song KS, Park YS et al (2003) Elevated levels of circulating platelet microparticles, VEGF, IL-6 and RANTES in patients with gastric cancer: possible role of a metastasis predictor. Eur J Cancer 39:184–191
Kogure T, Lin WL, Yan IK, Braconi C, Patel T (2011) Intercellular nanovesicle-mediated microRNA transfer: a mechanism of environmental modulation of hepatocellular cancer cell growth. Hepatology 54:1237–1248. doi:10.1002/hep.24504
Komatsu S, Ichikawa D, Takeshita H et al (2014) Circulating miR-18a: a sensitive cancer screening biomarker in human cancer. In Vivo 28:293–297
Lajer CB, Garnæs E, Friis-Hansen L et al (2012) The role of miRNAs in human papilloma virus (HPV)-associated cancers: bridging between HPV-related head and neck cancer and cervical cancer. Br J Cancer 106:1526–1534. doi:10.1038/bjc.2012.109
Lee TH, D’Asti E, Magnus N, Al-Nedawi K, Meehan B, Rak J (2011) Microvesicles as mediators of intercellular communication in cancer–the emerging science of cellular ‘debris’. Semin Immunopathol 33:455–467. doi:10.1007/s00281-011-0250-3
Lever AM, Jeang KT (2011) Insights into cellular factors that regulate HIV-1 replication in human cells. Biochemistry 50:920–931. doi:10.1021/bi101805f
Livak KJ, Schmittgen TD (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2(-ΔΔC(T)) method. Methods 25:402–408. doi:10.1006/meth.2001.1262
Ljubojevic S, Skerlev M (2014) HPV-associated diseases. Clin Dermatol 32:227–234. doi:10.1016/j.clindermatol.2013.08.007
Minciacchi VR, Freeman MR, Di Vizio D (2015) Extracellular vesicles in cancer: exosomes, microvesicles and the emerging role of large oncosomes. Semin Cell Dev Biol 40:41–51. doi:10.1016/j.semcdb.2015.02.010
Misso G, Di Martino MT, De Rosa G et al (2014) Mir-34: a new weapon against cancer? Mol Ther Nucleic Acids 3:e194. doi:10.1038/mtna.2014.47
Muralidharan-Chari V, Clancy JW, Sedgwick A, D’Souza-Schorey C (2010) Microvesicles: mediators of extracellular communication during cancer progression. J Cell Sci 123:1603–1611. doi:10.1242/jcs.064386
Nalejska E, Mączyńska E, Lewandowska MA (2014) Prognostic and predictive biomarkers: tools in personalized oncology. Mol Diagn Ther 18:273–284. doi:10.1007/s40291-013-0077-9
Nouraee N, Calin GA (2013) MicroRNAs as cancer biomarkers. Microrna 2:102–117
Ohno M, Natsume A, Kondo Y et al (2009) The modulation of microRNAs by type I IFN through the activation of signal transducers and activators of transcription 3 in human glioma. Mol Cancer Res 7:2022–2030. doi:10.1158/1541-7786.MCR-09-0319
Pedersen IM, Cheng G, Wieland S, Volinia S, Croce CM, Chisari FV, David M (2007) Interferon modulation of cellular microRNAs as an antiviral mechanism. Nature 449:919–922. doi:10.1038/nature06205
Pegtel DM, Cosmopoulos K, Thorley-Lawson DA et al (2010) Functional delivery of viral miRNAs via exosomes. Proc Natl Acad Sci USA 107:6328–6333. doi:10.1073/pnas.0914843107
Ribeiro J, Sousa H (2014) MicroRNAs as biomarkers of cervical cancer development: a literature review on miR-125b and miR-34a. Mol Biol Rep 41:1525–1531. doi:10.1007/s11033-013-2998-0
Ruan K, Fang X, Ouyang G (2009) MicroRNAs: novel regulators in the hallmarks of human cancer. Cancer Lett 285:116–126. doi:10.1016/j.canlet.2009.04.031
Sun Y, Zhang B, Cheng J et al (2014) MicroRNA-222 promotes the proliferation and migration of cervical cancer cells. Clin Invest Med 37:E131
Toyota M, Suzuki H, Sasaki Y, Maruyama R, Imai K, Shinomura Y, Tokino T (2008) Epigenetic silencing of microRNA-34b/c and B-cell translocation gene 4 is associated with CpG island methylation in colorectal cancer. Cancer Res 68:4123–4132. doi:10.1158/0008-5472.CAN-08-0325
Umbach JL, Cullen BR (2009) The role of RNAi and microRNAs in animal virus replication and antiviral immunity. Genes Dev 23:1151–1164. doi:10.1101/gad.1793309
Vader P, Breakefield XO, Wood MJ (2014) Extracellular vesicles: emerging targets for cancer therapy. Trends Mol Med 20:385–393. doi:10.1016/j.molmed.2014.03.002
Valencia K, Luis-Ravelo D, Bovy N et al (2014) miRNA cargo within exosome-like vesicle transfer influences metastatic bone colonization. Mol Oncol 8:689–703. doi:10.1016/j.molonc.2014.01.012
Wang X, Wang HK, McCoy JP et al (2009) Oncogenic HPV infection interrupts the expression of tumor-suppressive miR-34a through viral oncoprotein E6. RNA 15:637–647. doi:10.1261/rna.1442309
Wang X, Wang HK, Li Y et al (2014) microRNAs are biomarkers of oncogenic human papillomavirus infections. Proc Natl Acad Sci USA 111:4262–4267. doi:10.1073/pnas.1401430111
Webber J, Yeung V, Clayton A (2015) Extracellular vesicles as modulators of the cancer microenvironment. Semin Cell Dev Biol 40:27–34. doi:10.1016/j.semcdb.2015.01.013
Zheng ZM, Wang X (2011) Regulation of cellular miRNA expression by human papillomaviruses. Biochim Biophys Acta 1809:668–677. doi:10.1016/j.bbagrm.2011.05.005
zur Hausen H (2009) Papillomaviruses in the causation of human cancers—a brief historical account. Virology 384:260–265. doi:10.1016/j.virol.2008.11.046
Acknowledgments
Research in our laboratory is funded in part by Research Projects, Sapienza University of Rome, 2013–2014.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Ethical approval
This article does not contain any studies with human participants or animals performed by any of the authors.
Additional information
Gianna Fiorucci and Giovanna Romeo have contributed equally to this study and are listed in alphabetical order.
Electronic supplementary material
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Chiantore, M.V., Mangino, G., Iuliano, M. et al. Human papillomavirus E6 and E7 oncoproteins affect the expression of cancer-related microRNAs: additional evidence in HPV-induced tumorigenesis. J Cancer Res Clin Oncol 142, 1751–1763 (2016). https://doi.org/10.1007/s00432-016-2189-1
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00432-016-2189-1